$ 0.01
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Regen BioPharma, Inc. is dedicated to advancing regenerative medicine solutions across the United States. The company's scientific endeavors involve identifying small molecules that modulate NR2F6, with the aim of either stimulating immune cells for cancer treatments or suppressing them for managing autoimmune conditions. Currently, its product pipeline and therapeutic approaches are in nascent developmental phases. Established in 2012, Regen BioPharma, Inc. operates from its headquarters in La Mesa, California.
Company Valuation
From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks.
Data is available to registered users only